Abstract
Occupational exposure to beryllium (Be) and Be compounds occurs in a wide range of industrial processes. A large number of workers are potentially exposed to this metal during manufacturing and processing, so there is a concern regarding the potential carcinogenic hazard of Be. Studies were performed to determine the carcinogenic potential of beryllium sulfate (BeSO4) in cultured mammalian cells. BALB/c‐3T3 cells were treated with varying concentrations of BeSO4 for 72 h and the transformation frequency was determined after 4 weeks of culturing. Concentrations from 50–200 μg BeSO4/ml, caused a concentration‐dependent increase (9–41 fold) in transformation frequency. Non‐transformed BALB/c‐3T3 cells and cells from transformed foci induced by BeSO4 were injected into both axillary regions of nude mice. All ten Be‐induced transformed cell lines injected into nude mice produced fibrosarcomas within 50 days after cell injection. No tumors were found in nude mice receiving non‐transformed BALB/c‐3T3 cells 90 days post‐injection. Gene amplification was investigated in K‐ras, c‐myc, c‐fos, c‐jun, c‐sis, erb‐B2 and p53 using differential PCR while random amplified polymorphic DNA fingerprinting was employed to detect genomic instability. Gene amplification was found in K‐ras and c‐jun, however no change in gene expression or protein level was observed in any of the genes by Western blotting. Five of the 10 transformed cell lines showed genetic instability using different random primers. In conclusion, these results indicate that BeSO4 is capable of inducing morphological cell transformation in mammalian cells and that transformed cells induced by BeSO4 are potentially tumorigenic. Also, cell transformation induced by BeSO4 may be attributed, in part, to the gene amplification of K‐ras and c‐jun and some BeSO4‐induced transformed cells possess neoplastic potential resulting from genomic instability.
Similar content being viewed by others
References
WHO: Beryllium (Environmental Health Criteria 106). Geneva, 1990
IARC Monographs on the Evaluation of the Carcinogenic Risk to Humans: Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Lyon 58: 41–117, 1993
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some metals and metallic compounds. Lyon 23: 143–204, 1980
Flamm WG: Beryllium: Laboratory evidence. IARC Sci Publ 65: 199–201, 1985
Ashby J, Ishidate M Jr, Stoner GD, Morgan MA, Ratpan F, Callander RD: Studies on the genotoxicity of beryllium sulphate in vitro and in vivo. Mutat Res 240: 217–225, 1990
Dunkel VC, Zeiger E, Brusick D, McCoy E, McGregor D, Mortelmans K, Rosenkranz HS, Simmon VF: Reproducibility of microbial mutagenicity assays: I. Tests with Salmonella typhimurium and Escherichia coli using a standardized protocol. Environ Mutagen 6: 1–251, 1984
Kuroda K, Endo G, Okamoto A, Yo YS, Horiguchi S-I: Genotoxicity of beryllium, gallium and antimony in short-term assays. Mutat Res 264: 163–170, 1991
Arlauskas A, Baker RS, Bonin AM, Tandon RK, Crisp PT, Ellis J: Mutagenicity of metal ions in bacteria. Environ Res 36: 379–388, 1985
Larramendy ML, Popescu NC, DiPaolo JA: Induction by inorganic metal salts of sister chromatid exchanges and chromosome aberration in human and Syrian hamster cell strains. Environ Mutagen 3: 597–606, 1981
Miyaki M, Akamatsu N, Ono T, Koyama H: Mutagenicity of metal cations in cultured cells from Chinese hamster. Mutat Res 68: 259–263, 1979
Dunkel VC, Pienta RJ, Sivak A, Traul KA: Comparative neoplastic transformation responses of Balb/3T3 cells, Syrian hamster embryo cells, and Rauscher murine leukemia virus-infected Fischer 344 rat embryo cells to chemical carcinogens. J Natl Cancer Inst 67: 1303–1315, 1981
DiPaolo JA, Casto BC: Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res 39: 1008–1013, 1979
Steel VE, Wilkinson BP, Arnold JT, Kutzman RS: Study of beryllium oxide genotoxicity in cultured respiratory epithelial cells. Inhal Toxicol 1: 95–110, 1989
Finch GL, Hoover MD, Hahn FF, Nikula KJ, Belinsky SA, Haley PJ, Griffith WC: Animal models of beryllium-induced lung disease. Environ Health Perspect 104: 973–979, 1996
LeBoeuf RA, Kerchaert KA, Aardema MJ, Isfort RJ: The use of shortand medium-term tests for carcinogens and data on genetic effects. In: D.B. McGregor, J.M. Rice, S. Venitt (eds). Carcinogenic Hazard Evaluation. IARC Sci Publ 146: 409–425, 1999
Stutman O: In: J. Fogh, B. Giovanella (eds). The Nude Mouse in Experimental and Clinical Research. Academic Press, New York, 1978, pp 411–435
Dunkel VC, Rogers C, Swierenga SHH, Brillinger RL, Gilman JPW, Nestmann ER: Recommended protocols based on a survey of current practice in genotoxicity testing laboratories: III. Cell transformation in C3H/10T1/2 mouse embryo cell, BALB/c 3T3 mouse fibroblast and Syrian hamster embryo cell cultures. Mutat Res 246: 285–300, 1991
Sambrook J, Fritsch EF, Maniatis T: In: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1980
Niman HL, Thompson AMH, Yu A, Markham M, Willems JJ, Herwig KR, Habib NA, Wood CB: Antipeptide antibodies to detect oncogenerelated proteins in urine. Proc Natl Acad Sci USA 82: 7924–7928, 1985
Simon VF: In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium. J Natl Cancer Inst 62: 911–918, 1979
Tso WW, Fung WP: Mutagenicity of metallic cations. Toxicol Lett 8: 195–200, 1981
Tu AS, Murray TA, Hatch KM, Sivak A, Milman HA: In vitro transformation of BALB/c-3T3 cells by chlorinated ethanes and ethylenes. Cancer Lett 28: 85–92, 1985
Fitzgerald DJ, Piccoli C, Yamasaki H: Detection of non-genotoxic carcinogens in the BALB/c 3T3 cell transformation/mutation assay system. Mutagenesis 4: 286–291, 1989
Colacci A, Vaccari M, Perocco P, Via CD, Silingardi P, Manzin E, Horn W, Grilli S: Enhancement of BALB/c 3T3 cells transformation by 1,2-dibromoethane promoting effect. Carcinogenesis 17: 225–231, 1996
MacDonald F, Ford CJ: In: Molecular Biology of Cancer. Bios Scientific Publisher, Oxford, 1997
Cooper G, Okenquist S, Silverman L: Transforming activity of DNA of chemically transformed and normal cells. Nature 284: 418–421, 1980
Berwald Y, Sachs L: In vitro transformation with chemical carcinogens. Nature 200: 1182–1184, 1963
Isford RJ, LeBoeuf RA: The Syrian hamster embryo (SHE) cell transformation system: A biologically relevant in vitro model - with carcinogen predicting capabilities - of in vivo multistage neoplastic transformation. Crit Rev Oncol 6: 251–260, 1995
Belinsky SA, Swafford DS, Finch GL, Mitchell CE, Kelly G, Hahn FF, Anderson MW, Nikula KJ: Alterations in the K-ras and p53 genes in rat lung tumors. Environ Health Perspect 105: 901–906, 1997
Nickell-Brady C, Hahn FF, Finch GL, Belinsky SA: Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis 15: 257–262, 1994
Finch GL, Hoover MD, Hahn FF, Nikula KJ, Belinsky SA, Haley PJ, Griffith WC: Animal models of beryllium-induced lung disease. Environ Health Perspect 104: 973–979, 1996
Gao H-G, Brick J, Ong S, Miller M, Whong W-Z, Ong T: Selective hyperexpression of c-jun oncoprotein by glass fiber-and silica-transformed BALB/c3T3 cells. Cancer Lett 112: 65–69, 1997
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keshava, N., Zhou, G., Spruill, M. et al. Carcinogenic potential and genomic instability of beryllium sulphate in BALB/c‐3T3 cells. Mol Cell Biochem 222, 69–76 (2001). https://doi.org/10.1023/A:1017911306449
Issue Date:
DOI: https://doi.org/10.1023/A:1017911306449